UBS Group AG - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 15 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q2 2020$376,000
+18700.0%
126,692
+12382.0%
0.00%
Q3 2019$2,0001,015
+760.2%
0.00%
Q1 2019$0
-100.0%
118
-89.6%
0.00%
Q4 2018$1,0000.0%1,139
+149.2%
0.00%
Q3 2018$1,000
-50.0%
457
+117.6%
0.00%
Q4 2017$2,000
-95.0%
210
-93.3%
0.00%
Q3 2017$40,000
+344.4%
3,117
+344.0%
0.00%
Q1 2017$9,000
-40.0%
702
-61.0%
0.00%
Q4 2016$15,000
+25.0%
1,802
+34.5%
0.00%
Q3 2016$12,000
-7.7%
1,340
-20.0%
0.00%
Q2 2016$13,000
+44.4%
1,675
+90.3%
0.00%
Q3 2015$9,000
+350.0%
880
+340.0%
0.00%
Q2 2015$2,0002000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
Worth Asset Management, LLC 10,956$20,4880.02%
Lindbrook Capital, LLC 782$1,4620.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders